The table below shows Relay Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$3.00M
$0.00
$677.00K
$7.68M
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
RLAY annual revenue (10-K history)
Relay Therapeutics, Inc. reported annual revenue of $15.36M for fiscal year 2025. That is up 53.4% from $10.01M in fiscal 2024. Over the 6 fiscal years shown, annual revenue declined from $82.65M (FY 2020) to $15.36M. Figures come from the company's audited annual reports as filed with the SEC.
